Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
04:44:08 EDT Sat 04 May 2024
Enter Symbol
or Name
USA
CA



News for U:EXAS from 2023-05-04 to 2024-05-03 - 38 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-05-01 06:00U:EXASNews ReleaseExact Sciences to Participate in May Investor Conference
2024-04-15 06:00U:EXASNews ReleaseExact Sciences Names Aaron Bloomer as New Chief Financial Officer
2024-04-11 06:00U:EXASNews ReleaseExact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes
2024-04-08 12:05U:EXASNews ReleaseExact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024
2024-04-08 06:00U:EXASNews ReleaseExact Sciences Schedules First Quarter 2024 Earnings Call
2024-04-04 06:05U:EXASNews ReleaseExact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment
2024-03-28 06:00U:EXASNews ReleaseExact Sciences Advances Development of Non-Endoscopic Oncoguard(TM) Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer
2024-03-27 08:05U:EXASNews ReleaseExact Sciences Named 2024 Gallup Exceptional Workplace Award Winner
2024-03-13 17:03U:EXASNews ReleaseThe New England Journal of Medicine Publishes Cologuard Plus(TM) Test Results from Pivotal BLUE-C Study
2024-03-07 07:59U:EXASNews ReleaseExact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon Cancer
2024-02-26 06:00U:EXASNews ReleaseExact Sciences to Participate in March Investor Conference
2024-02-21 16:05U:EXASNews ReleaseExact Sciences Announces Fourth Quarter 2023 Results
2024-02-01 06:00U:EXASNews ReleaseExact Sciences Schedules Fourth Quarter 2023 Earnings Call
2024-01-07 16:30U:EXASNews ReleaseExact Sciences Announces Preliminary Fourth Quarter 2023 Results
2024-01-02 06:00U:EXASNews ReleaseExact Sciences to participate in J.P. Morgan Healthcare Conference
2023-12-07 08:05U:EXASNews ReleaseExact Sciences Awards Grants to 23 Organizations Focused on Increasing Colorectal Cancer Screenings
2023-11-30 16:05U:EXASNews ReleaseExact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients
2023-11-17 07:10U:EXASNews ReleaseExact Sciences Files Patent Infringement Lawsuit Against Geneoscopy
2023-11-01 16:05U:EXASNews ReleaseExact Sciences Announces Third-Quarter 2023 Results
2023-11-01 06:00U:EXASNews ReleaseExact Sciences to participate in November investor conferences
2023-10-22 15:00U:EXASNews ReleaseNext-Generation Cologuard ‚ ® Test Demonstrates High Sensitivity and Specificity in Pivotal BLUE-C Study, Significantly Outperforming Fecal Immunochemical Testing (FIT) for Cancer and Precancer Detection
2023-10-20 18:08U:EXASNews ReleaseExact Sciences Advances Early Cancer Detection and Precision Oncology Programs with Data Presentations at ESMO 2023 Annual Congress
2023-10-09 06:00U:EXASNews ReleaseExact Sciences schedules third quarter 2023 earnings call
2023-10-09 05:58U:EXASNews ReleaseExact Sciences to Present Late-Breaking Data from Pivotal BLUE-C Study on Next-Generation Cologuard at ACG 2023
2023-09-12 08:35U:EXASNews ReleaseAgilent Technologies and Exact Sciences Agree to Terms of Sale for Resolution Bioscience
2023-09-01 06:00U:EXASNews ReleaseExact Sciences to participate in September investor conference
2023-08-30 07:30U:EXASNews ReleaseExact Sciences Lab and OncoExTra Test Selected by National Cancer Institute for ComboMATCH Clinical Trials
2023-08-21 07:57U:EXASNews ReleaseNot a Wall, But an Obstacle Course: New Findings Reveal Why 45-Year-Olds Are Avoiding Colorectal Cancer Screenings
2023-08-01 16:05U:EXASNews ReleaseExact Sciences Announces Second-Quarter 2023 Results
2023-07-10 06:00U:EXASNews ReleaseExact Sciences schedules second quarter 2023 earnings call
2023-06-21 07:14U:EXASNews ReleaseExact Sciences Advances Innovative Cancer Technologies and Approaches Through Visionary Collaborations
2023-06-20 16:05U:EXASNews ReleaseNext-generation Cologuard Test Demonstrates 94 Percent Sensitivity for Colorectal Cancer at 91 Percent Specificity, Raising the Bar in Non-invasive Screening
2023-06-01 08:00U:EXASNews ReleaseEXACT SCIENCES EARNS 2023 GREAT PLACE TO WORK ‚ ® CERTIFICATION ¢ „ ¢
2023-06-01 06:00U:EXASNews ReleaseExact Sciences to participate in June investor conferences
2023-05-26 06:58U:EXASNews ReleaseExact Sciences Presents New Long-Term Patient Outcomes in Multi-Cancer Early Detection and Breast Cancer Recurrence Testing at ASCO ‚ ® 2023
2023-05-17 07:00U:EXASNews ReleaseEXACT SCIENCES AWARDS GRANTS TO 18 ORGANIZATIONS FOCUSED ON INCREASING COLORECTAL CANCER SCREENINGS
2023-05-09 16:05U:EXASNews ReleaseExact Sciences Announces First Quarter 2023 Results
2023-05-09 06:37U:EXASNews ReleaseExact Sciences Extends Leadership in Colorectal Cancer Screening with New Data Presented at Digestive Disease Week ‚ ® Annual Meeting